We indeed observed that expression level of PAX6 was also significantly in SCLC higher than that in NSCLC, indicating that upregulation of PAX6 might play a general role on promotion of NE trans-differentiation in cancers (Supplementary Fig. S1e and S1f). Here, PAX6 is linked to non-small cell lung carcinoma.